Applications from the field of Pharma & Biopharma from Waters - page 4
Open paper Enhanced Risk Assessment for a Traditional LC Separation Method Using ICH Q14 Regulatory Principles and a Simplified HPLC System
LCMS
Enhanced Risk Assessment for a Traditional LC Separation Method Using ICH Q14 Regulatory Principles and a Simplified HPLC System
HPLC
Instrumentation
HPLC
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Walk-up Mass Confirmation of Glucagon-like Peptides (GLP-1) Using the Xevo™ G3 QTof Combined with RemoteAnalyzer® Open Access Software
LCMS
Walk-up Mass Confirmation of Glucagon-like Peptides (GLP-1) Using the Xevo™ G3 QTof Combined with RemoteAnalyzer® Open Access Software
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Characterizing “nature’s Ozempic ”: Non-targeted screening of berberine supplements using ion mobility high-resolution mass spectrometry
LCMS
Characterizing “nature’s Ozempic ”: Non-targeted screening of berberine supplements using ion mobility high-resolution mass spectrometry
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Ion Mobility
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Ion Mobility
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Determination of Fatty Acid Composition in Polysorbate 80 using HPLC with Charged Aerosol Detection
LCMS
Determination of Fatty Acid Composition in Polysorbate 80 using HPLC with Charged Aerosol Detection
HPLC
Instrumentation
HPLC
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Multipass Ion Mobility Separation of GLP-1 Receptor Agonist Impurities Using the SELECT SERIES™ Cyclic™ IMS
LCMS
Multipass Ion Mobility Separation of GLP-1 Receptor Agonist Impurities Using the SELECT SERIES™ Cyclic™ IMS
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Ion Mobility
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Ion Mobility
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Investigating the Strength of the Sense and Antisense Oligonucleotide Interaction to Form siRNA Duplexes Using the BioAccord™ LC-MS System
LCMS
Investigating the Strength of the Sense and Antisense Oligonucleotide Interaction to Form siRNA Duplexes Using the BioAccord™ LC-MS System
LC/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper LC-MS Analysis of Two mRNA Critical Quality Attributes: 5’-Capping Efficiency and Average Poly(A) Tail Length and Heterogeneity Using the Xevo™ MRT Mass Spectrometer
LCMS
LC-MS Analysis of Two mRNA Critical Quality Attributes: 5’-Capping Efficiency and Average Poly(A) Tail Length and Heterogeneity Using the Xevo™ MRT Mass Spectrometer
LC/MS, LC/MS/MS, LC/HRMS, LC/TOF, Software
Instrumentation
LC/MS, LC/MS/MS, LC/HRMS, LC/TOF, Software
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Enabling Reliable Heparin Sodium Nucleotidic Impurity Analysis with the Alliance™ iS Bio HPLC System with PDA Detector
LCMS
Enabling Reliable Heparin Sodium Nucleotidic Impurity Analysis with the Alliance™ iS Bio HPLC System with PDA Detector
HPLC
Instrumentation
HPLC
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Head to Tail Analysis of mRNA by RapiZyme™ MC1 and Cusativin
LCMS
Head to Tail Analysis of mRNA by RapiZyme™ MC1 and Cusativin
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Quantitation of N-Nitroso-Desmethyl- Diltiazem, an NDSRI Impurity of Diltiazem Hydrochloride in Drug Product Using LCMS/ MS
LCMS
Quantitation of N-Nitroso-Desmethyl- Diltiazem, an NDSRI Impurity of Diltiazem Hydrochloride in Drug Product Using LCMS/ MS
LC/MS, LC/MS/MS, LC/QQQ
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Waters
Industries
Pharma & Biopharma
